The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review

No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women

(2020) Robyn L. Woods et al.   CIRCULATION

Eicosanoids

(2020) Bruce D. Hammock et al.   AMERICAN JOURNAL OF PATHOLOGY

Lipoxins, RevD1 and 9, 13 HODE as the most important derivatives after an early incident of ischemic stroke

(2020) Małgorzata Szczuko et al.   Scientific Reports

Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis

(2020) Mai Yamakawa et al.   Journal of Stroke & Cerebrovascular Diseases

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

(2019) William A.E. Parker et al.   PLATELETS

IL-17–high asthma with features of a psoriasis immunophenotype

(2019) Jörgen Östling et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Measurement of Thromboxane Biosynthesis in Health and Disease

(2019) Carlo Patrono et al.   Frontiers in Pharmacology

Polyphenols: Modulators of Platelet Function and Platelet Microparticle Generation?

(2019) Borkwei Ed Nignpense et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Genetic Signatures in Ischemic Stroke: Focus on Aspirin Resistance

(2018) Kanika Vasudeva et al.   CNS & Neurological Disorders-Drug Targets

Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future

(2018) Harron Khan et al.   FOOD AND CHEMICAL TOXICOLOGY

Genistein Ameliorates Non-alcoholic Fatty Liver Disease by Targeting the Thromboxane A2 Pathway

(2018) Wenzhe Wang et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials

(2018) Peter M Rothwell et al.   LANCET

Associations between thromboxane A synthase 1 gene polymorphisms and the risk of ischemic stroke in a Chinese Han population

(2018) Zhi-yi He et al.   Neural Regeneration Research

Drawing a link between the thromboxane A 2 pathway and the role of platelets and tumor cells in ovarian cancer

(2018) Karolina Serhan et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury

(2018) Yukihito Nakano et al.   HYPERTENSION RESEARCH

Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours

(2018) Cati Racca et al.   PLATELETS

Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss

(2018) Paola Simeone et al.   Nutrients

The definition of stroke

(2017) Alexander P Coupland et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients

(2017) Xingyang Yi et al.   PLoS One

Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells

(2017) Zhihong Zhao et al.   Oncotarget

Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis

(2017) Katherine L. Tucker et al.   PLOS MEDICINE

Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis

(2016) Vivan J. M. Baggen et al.   EUROPEAN RADIOLOGY

Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography

(2016) Kevin P. Bliden et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury

(2016) Aijuan Yan et al.   Scientific Reports

Urinary 11‐Dehydro‐Thromboxane B2as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

(2016) Wojciech Szczeklik et al.   Journal of the American Heart Association

Gadolinium Enhancement in Intracranial Atherosclerotic Plaque and Ischemic Stroke: A Systematic Review and Meta‐Analysis

(2016) Ajay Gupta et al.   Journal of the American Heart Association

Inflammation in acute CNS injury: a focus on the role of substance P

(2015) F Corrigan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Demyelination as a rational therapeutic target for ischemic or traumatic brain injury

(2015) Hong Shi et al.   EXPERIMENTAL NEUROLOGY

G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity

(2015) Matthias R Meyer et al.   JOURNAL OF ENDOCRINOLOGY

Arachidonic acid metabolites and endothelial dysfunction of portal hypertension

(2015) David Sacerdoti et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

(2015) N. S. Abraham et al.   BMJ-British Medical Journal

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

(2015) N. S. Abraham et al.   BMJ-British Medical Journal

Current concepts in the diagnosis and management of cytokine release syndrome

(2014) D. W. Lee et al.   BLOOD

The epidemiology of silent brain infarction: a systematic review of population-based cohorts

(2014) Jonathon P Fanning et al.   BMC Medicine

Antiplatelet Effect of Catechol Is Related to Inhibition of Cyclooxygenase, Reactive Oxygen Species, ERK/p38 Signaling and Thromboxane A2 Production

(2014) Mei-Chi Chang et al.   PLoS One

Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repair

(2014) Chengrui An et al.   PROGRESS IN NEUROBIOLOGY

Guidelines for the Primary Prevention of Stroke

(2014) James F. Meschia et al.   STROKE

Aspirin nonresponders in patients with ischaemic stroke

(2013) Pornpatr A. Dharmasaroja et al.   BLOOD COAGULATION & FIBRINOLYSIS

Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel

(2013) Plínio Cunha Sathler et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Association of thromboxane A2 receptor gene polymorphisms with cerebral infarction in a Chinese population

(2013) Jing Zhao et al.   NEUROLOGICAL SCIENCES

Antiplatelet Drugs

(2012) John W. Eikelboom et al.   CHEST

Primary and Secondary Prevention of Cardiovascular Disease

(2012) Per Olav Vandvik et al.   CHEST

High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets

(2012) I. Russo et al.   DIABETES

Short- and Long-Term Blood Pressure Variability

(2012) Giuseppe Mancia   HYPERTENSION

Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke

(2012) Valérie Capra et al.   MEDICINAL RESEARCH REVIEWS

Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials

(2012) Jing Zhang et al.   NEUROLOGICAL RESEARCH

Managing patients with multimorbidity: systematic review of interventions in primary care and community settings

(2012) S. M. Smith et al.   BMJ-British Medical Journal

Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation

(2010) Steven D. Douglas et al.   Annals of the New York Academy of Sciences

Thromboxane and the thromboxane receptor in cardiovascular disease

(2010) Emer M Smyth   Clinical Lipidology

The role of weight and enteric coating on aspirin response in cardiovascular patients

(2010) A. PEACE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS